Replies to post #21704 on Biotech Values

[rkrw]

There's a lot of goals in hcv. Foremost is getting success rates much better than 50%. Patients go through hell for 50/50 odds. Replacing ifn. Replacing ribavirin. Shorter treatment times. All oral. I'd put better success at the top and go from there. 950 may be transforming if they can both boost cure rates and shorten treatment.

[Praveen]

RNAI/Thomas

Hi Thomas,

Do you have a particular interest in any of RNA Interference companies?

Thanks,
Praveen